Nutrient-Drug Interactions
List Price:
$89.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Kelly Anne Meckling
Format:
Paperback
Pages:
352
Publisher:
CRC Press (September 5, 2019)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9780367390655
Weight:
16oz
Dimensions:
6" x 9"
File:
TAYLORFRANCIS-TayFran_260403050835162-20260403.xml
Folder:
TAYLORFRANCIS
List Price:
$89.99
Country of Origin:
United States
As low as:
$85.49
Publisher Identifier:
P-CRC
Discount Code:
H
Pub Discount:
30
Case Pack:
1
Imprint:
CRC Press
Overview
Focusing on food, herbals, and their chemical constituents, this book discusses how they contribute to health through control of metabolism, primarily as they relate to chronic disease development and treatment. Each chapter provides a comprehensive examination of the macronutrient, micronutrient, and phytochemical impact on drug action and includes advice on modification or supplementation in those cases where diet is a factor. The book describes the roles of genetic variation and polymorphism in determining nutrient/drug responses, how they might be "profiled" to identify those likely to demonstrate specific interactions, and who would benefit from adjuvant or complementary therapies.
